#8559. Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis

February 2027publication date
Proposal available till 30-05-2025
5 total number of authors per manuscript6020 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Biochemistry, Genetics and Molecular Biology (miscellaneous);
Medicine (miscellaneous);
Molecular Medicine;
Cell Biology;
Places in the authors’ list:
place 1place 2place 3place 4place 5
FreeFreeFreeFreeFree
2230 $1120 $1000 $890 $780 $
Contract №8559.1 Contract №8559.2 Contract №8559.3 Contract №8559.4 Contract №8559.5
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)
5 place - free (for sale)

Abstract:
This study discusses microfluidic technologies for neuroblastoma removal from stem cell products.
Keywords:
Acoustophoresis; Neuroblastoma; Patient-derived xenografts; Peripheral blood progenitor cells; Purging; Stem cell transplantation

Contacts :
0